nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—PDE3B—cardiovascular system—nicotine dependence	0.0545	0.106	CbGeAlD
Oxtriphylline—PDE4C—midbrain—nicotine dependence	0.0403	0.0788	CbGeAlD
Oxtriphylline—ADORA2A—cardiovascular system—nicotine dependence	0.0376	0.0734	CbGeAlD
Oxtriphylline—PDE3A—cardiovascular system—nicotine dependence	0.0333	0.065	CbGeAlD
Oxtriphylline—ADORA1—cardiovascular system—nicotine dependence	0.0324	0.0634	CbGeAlD
Oxtriphylline—HDAC2—cardiovascular system—nicotine dependence	0.032	0.0626	CbGeAlD
Oxtriphylline—PDE3B—brain—nicotine dependence	0.0267	0.0522	CbGeAlD
Oxtriphylline—PDE4C—brain—nicotine dependence	0.0253	0.0495	CbGeAlD
Oxtriphylline—ADORA1—midbrain—nicotine dependence	0.0253	0.0495	CbGeAlD
Oxtriphylline—HDAC2—midbrain—nicotine dependence	0.025	0.0489	CbGeAlD
Oxtriphylline—PDE4D—brain—nicotine dependence	0.0223	0.0436	CbGeAlD
Oxtriphylline—ADORA2B—brain—nicotine dependence	0.0222	0.0433	CbGeAlD
Oxtriphylline—PDE4A—brain—nicotine dependence	0.0197	0.0386	CbGeAlD
Oxtriphylline—PDE4B—midbrain—nicotine dependence	0.0187	0.0366	CbGeAlD
Oxtriphylline—ADORA2A—brain—nicotine dependence	0.0184	0.036	CbGeAlD
Oxtriphylline—SLC22A7—brain—nicotine dependence	0.0183	0.0357	CbGeAlD
Oxtriphylline—HDAC2—p75 NTR receptor-mediated signalling—FGD1—nicotine dependence	0.0165	0.0339	CbGpPWpGaD
Oxtriphylline—PDE3A—brain—nicotine dependence	0.0163	0.0319	CbGeAlD
Oxtriphylline—ADORA1—brain—nicotine dependence	0.0159	0.0311	CbGeAlD
Oxtriphylline—HDAC2—brain—nicotine dependence	0.0157	0.0307	CbGeAlD
Oxtriphylline—PDE4C—Opioid Signalling—OPRM1—nicotine dependence	0.0139	0.0285	CbGpPWpGaD
Oxtriphylline—PDE4D—Opioid Signalling—OPRM1—nicotine dependence	0.0121	0.0248	CbGpPWpGaD
Oxtriphylline—PDE4B—brain—nicotine dependence	0.0118	0.023	CbGeAlD
Oxtriphylline—PDE4A—Opioid Signalling—OPRM1—nicotine dependence	0.0115	0.0236	CbGpPWpGaD
Oxtriphylline—ADORA1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0109	0.0224	CbGpPWpGaD
Oxtriphylline—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.0108	0.0222	CbGpPWpGaD
Oxtriphylline—PDE4B—Opioid Signalling—OPRM1—nicotine dependence	0.0107	0.0219	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00778	0.0159	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00662	0.0136	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—FGD1—nicotine dependence	0.00609	0.0125	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—FGD1—nicotine dependence	0.00566	0.0116	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00511	0.0105	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.0051	0.0105	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00503	0.0103	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00482	0.00987	CbGpPWpGaD
Oxtriphylline—ADORA1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00461	0.00944	CbGpPWpGaD
Oxtriphylline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0045	0.00922	CbGpPWpGaD
Oxtriphylline—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00444	0.0091	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0044	0.00901	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00438	0.00897	CbGpPWpGaD
Oxtriphylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00431	0.00883	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00427	0.00876	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00426	0.00874	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00424	0.00869	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00419	0.0086	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00399	0.00818	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00399	0.00818	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00394	0.00808	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00388	0.00796	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00387	0.00794	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—TAS2R16—nicotine dependence	0.00381	0.00781	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—FGD1—nicotine dependence	0.00378	0.00775	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—DRD2—nicotine dependence	0.00377	0.00773	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00374	0.00766	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00369	0.00757	CbGpPWpGaD
Oxtriphylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00366	0.00751	CbGpPWpGaD
Oxtriphylline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00365	0.00747	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00363	0.00745	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00363	0.00743	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00353	0.00723	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00345	0.00707	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—FGD1—nicotine dependence	0.00343	0.00704	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—TAS2R16—nicotine dependence	0.0034	0.00696	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00335	0.00687	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—FGD1—nicotine dependence	0.00335	0.00686	CbGpPWpGaD
Oxtriphylline—ADORA1—G alpha (i) signalling events—DRD2—nicotine dependence	0.00333	0.00682	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0033	0.00676	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—FGD1—nicotine dependence	0.00329	0.00675	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00328	0.00672	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—DRD2—nicotine dependence	0.00313	0.00642	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—FGD1—nicotine dependence	0.00313	0.00642	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—FGD1—nicotine dependence	0.00313	0.00642	CbGpPWpGaD
Oxtriphylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00311	0.00638	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00309	0.00633	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—FGD1—nicotine dependence	0.00305	0.00625	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—FGD1—nicotine dependence	0.00304	0.00623	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—FGD1—nicotine dependence	0.00299	0.00613	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—FGD1—nicotine dependence	0.00293	0.00601	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—DRD2—nicotine dependence	0.00291	0.00597	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—FGD1—nicotine dependence	0.0029	0.00594	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00289	0.00592	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—FGD1—nicotine dependence	0.00285	0.00583	CbGpPWpGaD
Oxtriphylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00283	0.00579	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR ligand binding—OPRM1—nicotine dependence	0.00279	0.00572	CbGpPWpGaD
Oxtriphylline—SLC22A7—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00277	0.00568	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—FGD1—nicotine dependence	0.00277	0.00567	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—FGD1—nicotine dependence	0.00266	0.00546	CbGpPWpGaD
Oxtriphylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00265	0.00543	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—FGD1—nicotine dependence	0.00263	0.00539	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00262	0.00537	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TAS2R16—nicotine dependence	0.00258	0.0053	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—CCAR1—nicotine dependence	0.00256	0.00525	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00239	0.00489	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR ligand binding—DRD2—nicotine dependence	0.00237	0.00486	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.00236	0.00483	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TAS2R16—nicotine dependence	0.00229	0.00469	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.00227	0.00464	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TAS2R16—nicotine dependence	0.00225	0.00461	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.00215	0.00441	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TAS2R16—nicotine dependence	0.00214	0.00439	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TAS2R16—nicotine dependence	0.00208	0.00427	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—FGD1—nicotine dependence	0.00206	0.00422	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00205	0.00421	CbGpPWpGaD
Oxtriphylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00204	0.00419	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—OPRM1—nicotine dependence	0.00203	0.00416	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—FGD1—nicotine dependence	0.00203	0.00416	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR ligand binding—DRD2—nicotine dependence	0.00202	0.00413	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TAS2R16—nicotine dependence	0.00201	0.00411	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TAS2R16—nicotine dependence	0.00198	0.00406	CbGpPWpGaD
Oxtriphylline—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.00194	0.00397	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00191	0.00391	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00185	0.0038	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—FGD1—nicotine dependence	0.00185	0.00379	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—OPRM1—nicotine dependence	0.00184	0.00378	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—OPRM1—nicotine dependence	0.0018	0.00368	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—FGD1—nicotine dependence	0.0018	0.00368	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—AKR1B10—nicotine dependence	0.00179	0.00367	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—OPRM1—nicotine dependence	0.00177	0.00362	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—FGD1—nicotine dependence	0.00177	0.00362	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.00168	0.00345	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00168	0.00345	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—FGD1—nicotine dependence	0.00168	0.00344	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TAS2R16—nicotine dependence	0.00167	0.00341	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—AKR1B10—nicotine dependence	0.00165	0.00338	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00164	0.00336	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.00163	0.00335	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—FGD1—nicotine dependence	0.00163	0.00335	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—OPRM1—nicotine dependence	0.00163	0.00335	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—OPRM1—nicotine dependence	0.00161	0.00329	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—AKR1B10—nicotine dependence	0.00159	0.00325	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00158	0.00323	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—FGD1—nicotine dependence	0.00157	0.00323	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—AKR1B10—nicotine dependence	0.00156	0.0032	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00156	0.00319	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—DRD2—nicotine dependence	0.00156	0.00319	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—FGD1—nicotine dependence	0.00156	0.00319	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.00155	0.00317	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—OPRM1—nicotine dependence	0.00153	0.00313	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—OPRM1—nicotine dependence	0.00149	0.00305	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—AKR1B10—nicotine dependence	0.00148	0.00304	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—DRD2—nicotine dependence	0.00147	0.00301	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—AKR1B10—nicotine dependence	0.00144	0.00296	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—OPRM1—nicotine dependence	0.00143	0.00293	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—OPRM1—nicotine dependence	0.00141	0.0029	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—AKR1B10—nicotine dependence	0.00139	0.00285	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—AKR1B10—nicotine dependence	0.00137	0.00281	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.00134	0.00275	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—DRD2—nicotine dependence	0.00133	0.00273	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FGD1—nicotine dependence	0.00131	0.00268	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—DRD2—nicotine dependence	0.0013	0.00266	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—DRD2—nicotine dependence	0.00128	0.00262	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—WASF2—nicotine dependence	0.00126	0.00259	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—DRD2—nicotine dependence	0.00122	0.00249	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—DRD2—nicotine dependence	0.00122	0.00249	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00122	0.00249	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FGD1—nicotine dependence	0.00122	0.00249	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—WASF1—nicotine dependence	0.00121	0.00248	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—DRD2—nicotine dependence	0.00118	0.00243	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—DRD2—nicotine dependence	0.00118	0.00242	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—DRD2—nicotine dependence	0.00116	0.00238	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AKR1B10—nicotine dependence	0.00115	0.00237	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—WASF2—nicotine dependence	0.00115	0.00236	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—DRD2—nicotine dependence	0.00114	0.00234	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—DRD2—nicotine dependence	0.00113	0.00231	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—WASF2—nicotine dependence	0.00112	0.00229	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—DRD2—nicotine dependence	0.00111	0.00226	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.00111	0.00226	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—WASF1—nicotine dependence	0.0011	0.00226	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—WASF2—nicotine dependence	0.0011	0.00225	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—OPRM1—nicotine dependence	0.00109	0.00223	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—DRD2—nicotine dependence	0.00107	0.0022	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.00107	0.0022	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—WASF1—nicotine dependence	0.00107	0.00219	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—WASF1—nicotine dependence	0.00105	0.00216	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—WASF2—nicotine dependence	0.00105	0.00214	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—DRD2—nicotine dependence	0.00103	0.00212	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—DRD2—nicotine dependence	0.00102	0.0021	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—WASF2—nicotine dependence	0.00102	0.00209	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—WASF1—nicotine dependence	0.001	0.00206	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—OPRM1—nicotine dependence	0.000994	0.00204	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—WASF2—nicotine dependence	0.000979	0.00201	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—WASF1—nicotine dependence	0.000976	0.002	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—WASF2—nicotine dependence	0.000968	0.00198	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—OPRM1—nicotine dependence	0.000964	0.00198	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—OPRM1—nicotine dependence	0.000949	0.00194	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—WASF1—nicotine dependence	0.000939	0.00192	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—WASF1—nicotine dependence	0.000928	0.0019	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—OPRM1—nicotine dependence	0.000903	0.00185	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.00088	0.0018	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—OPRM1—nicotine dependence	0.000878	0.0018	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—OPRM1—nicotine dependence	0.000846	0.00173	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—OPRM1—nicotine dependence	0.000835	0.00171	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—WASF2—nicotine dependence	0.000813	0.00167	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000799	0.00164	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—DRD2—nicotine dependence	0.000788	0.00161	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—WASF1—nicotine dependence	0.00078	0.0016	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—WASF2—nicotine dependence	0.000756	0.00155	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—WASF1—nicotine dependence	0.000725	0.00149	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—DRD2—nicotine dependence	0.000719	0.00147	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—OPRM1—nicotine dependence	0.000702	0.00144	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—DRD2—nicotine dependence	0.000697	0.00143	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—DRD2—nicotine dependence	0.000686	0.00141	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—DRD2—nicotine dependence	0.000653	0.00134	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000653	0.00134	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—DRD2—nicotine dependence	0.000635	0.0013	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—DRD2—nicotine dependence	0.000611	0.00125	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—DRD2—nicotine dependence	0.000604	0.00124	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—DRD2—nicotine dependence	0.000508	0.00104	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—DRD2—nicotine dependence	0.000472	0.000967	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000331	0.000679	CbGpPWpGaD
